Abstract:Vascular endothelial growth factor (VEGF) represents a growth factor with important pro-angiogenic activity, having a mitogenic and an anti-apoptotic effect on endothelial cells, increasing the vascular permeability, promoting cell migration, etc. Due to these effects, it actively contributes in regulating the normal and pathological angiogenic processes. In humans, the VEGF family is composed of several members: VEGF-A (which has different isoforms), VEGF-B, VEGF-C, VEGF-D, VEGF-E (viral VEGF), VEGF-F (snake venom VEGF), placenta growth factor (PlGF), and, recently, to this family has been added endocrine gland-derived vascular endothelial growth factor (EG-VEGF). VEGF binds to tyrosine kinase cell receptors (VEGFRs): VEGFR-1 [Fms-like tyrosine kinase 1 (Flt-1)], VEGFR-2 [kinase insert domain receptor (KDR) in human; fetal liver kinase 1 (Flk-1) in mouse] and VEGFR-3 [Fms-like tyrosine kinase 4 (Flt-4)]. While VEGFR-1 and VEGFR-2 are expressed predominantly on vascular endothelial cells, VEGFR-3 is expressed especially on lymphatic endothelial cells. VEGFR-2 has the strongest pro-angiogenic activity and a higher tyrosine kinase activity than VEGFR-1. Endothelial cells also express co-receptors, such as neuropilin-1 (NP-1) and neuropilin-2 (NP-2), which modulate tyrosine kinase receptor activity. Both VEGF and VEGFRs are expressed not only on endothelial cells, but also on non-endothelial cells. This article aims to highlight the most recent data referring to the VEGF family and its receptors, as well as its implications in the angiogenesis process. At present, blocking angiogenesis in cancer or in other pathological processes, using anti-VEGF and anti-VEGFRs therapies, is considered to be extremely important.

Non-angiogenic functions of vascular endothelial growth factor]

VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications

Osteogenic Role of Vascular Endothelial Growth Factor in Bone Regeneration.

Vascular Endothelial Growth Factor and Atherosclerosis

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

VEGF in biological control

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

Structure and Function of Vascular Endothelial Growth Factor and Its Related Proteins

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis

Novel VEGF Family Members: VEGF-B, VEGF-C and VEGF-D.

The Vascular Endothelial Growth Factor Family and Antiangiogesis Therapy

The biology of VEGF and its receptors

Vascular Endothelial Growth Factor-B: Impact on Physiology and Pathology.

Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy

Vegf-B Is Dispensable For Blood Vessel Growth But Critical For Their Survival, And Vegf-B Targeting Inhibits Pathological Angiogenesis

VEGF-B: a survival, or an angiogenic factor?

Vascular Endothelial Growth Factors and Liver Diseases.

Biology and therapeutic targeting of vascular endothelial growth factor A

Researching progress in the functions of VEGF receptor

VEGF Signal System: the Application of Antiangiogenesis.